Skip to main content

Century Therapeutics, Inc.

IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850119

In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Century Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of IPSC: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders61167+7
Shares40.1M2.90M39.6M+2.43M (+6.5%)
Value$102.3M$7.38M$67.8M−$27.1M (−28.6%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Century Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to IPSC in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.2,989,920$5.11M0.00%
Wellington Management Group LLP166,123$284.1K0.00%
Acadian Asset Management LLC119,384$202.0K0.00%
Squarepoint Ops LLC105,697$180.7K0.00%
AQR Capital Management LLC20,861$35.7K0.00%
Lynx1 Capital Management LP19,028$32.5K0.01%
SG Americas Securities, LLC16,081$27.0K0.00%
Smartleaf Asset Management LLC1,609$2.59K0.00%
Advisor Group Holdings, Inc.1,090$1.86K0.00%
Mark Sheptoff Financial Planning, LLC500$8550.00%
Sterling Capital Management LLC146$2500.00%
Capital Performance Advisors LLP12$210.00%

Sold out (5)

Institutions that held Century Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of IPSC in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Federated Hermes, Inc.276,163$704.2K
Jacobs Levy Equity Management, Inc10,583$27.0K
Russell Investments Group, Ltd.5,842$14.9K
Public Employees Retirement System of Ohio100$255
Simplex Trading, LLC68$0

Not filed for Q3 2024 yet (1)

Institutions that held Century Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IPSC in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.2,895,613$7.38M